These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32422014)

  • 21. The microbiome and autoimmune disease: Report from a Noel R. Rose Colloquium.
    Barin JG; Tobias LD; Peterson DA
    Clin Immunol; 2015 Aug; 159(2):183-8. PubMed ID: 26003843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies.
    Wiertsema SP; van Bergenhenegouwen J; Garssen J; Knippels LMJ
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microbiome-immune-host defense barrier complex (microimmunosome) and developmental programming of noncommunicable diseases.
    Dietert RR
    Reprod Toxicol; 2017 Mar; 68():49-58. PubMed ID: 27167696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The human microbiome].
    Salzberger B; Lehnert H; Mössner J
    Internist (Berl); 2017 May; 58(5):427-428. PubMed ID: 28405695
    [No Abstract]   [Full Text] [Related]  

  • 25. Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution.
    Mejía-León ME; Barca AM
    Nutrients; 2015 Nov; 7(11):9171-84. PubMed ID: 26561831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the intestinal microbiome in autoimmune diseases and its use in treatments.
    Marietta E; Horwath I; Balakrishnan B; Taneja V
    Cell Immunol; 2019 May; 339():50-58. PubMed ID: 30366573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings.
    Mukherjee S; Joardar N; Sengupta S; Sinha Babu SP
    J Nutr Biochem; 2018 Nov; 61():111-128. PubMed ID: 30196243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Modern-World View of Host-Microbiota-Pathogen Interactions.
    Tan CY; Ramirez ZE; Surana NK
    J Immunol; 2021 Oct; 207(7):1710-1718. PubMed ID: 34544813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory interplay of the microbiome and therapy of rheumatic diseases.
    Ostrov BE; Amsterdam D
    Immunol Invest; 2017 Nov; 46(8):769-792. PubMed ID: 29058546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human gut microbiome: hopes, threats and promises.
    Cani PD
    Gut; 2018 Sep; 67(9):1716-1725. PubMed ID: 29934437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The microbiome in autoimmune diseases.
    De Luca F; Shoenfeld Y
    Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the bacterial microbiome in the treatment of cancer.
    Yu ZK; Xie RL; You R; Liu YP; Chen XY; Chen MY; Huang PY
    BMC Cancer; 2021 Aug; 21(1):934. PubMed ID: 34412621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
    Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
    Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.
    Dzutsev A; Goldszmid RS; Viaud S; Zitvogel L; Trinchieri G
    Eur J Immunol; 2015 Jan; 45(1):17-31. PubMed ID: 25328099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity.
    Secombe KR; Coller JK; Gibson RJ; Wardill HR; Bowen JM
    Int J Cancer; 2019 May; 144(10):2365-2376. PubMed ID: 30155890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen sulfide: An endogenous regulator of the immune system.
    Dilek N; Papapetropoulos A; Toliver-Kinsky T; Szabo C
    Pharmacol Res; 2020 Nov; 161():105119. PubMed ID: 32781284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiome and autoimmune disorders.
    Shaheen WA; Quraishi MN; Iqbal TH
    Clin Exp Immunol; 2022 Aug; 209(2):161-174. PubMed ID: 35652460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the microbiome on cancer progression and response to anti-cancer therapies.
    Buchta Rosean C; Feng TY; Azar FN; Rutkowski MR
    Adv Cancer Res; 2019; 143():255-294. PubMed ID: 31202360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recognizing that the microbiome is part of the human immune system will advance treatment of both cancer and infections.
    Gallo RL; Hultsch T; Farnaes L
    J Am Acad Dermatol; 2016 Apr; 74(4):772-4. PubMed ID: 26979362
    [No Abstract]   [Full Text] [Related]  

  • 40. The Microbiome and Pancreatic Cancer: An Evidence-based Association?
    Archibugi L; Signoretti M; Capurso G
    J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S82-S85. PubMed ID: 30001289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.